Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival

Laboratory models show that the beta-blocker, propranolol, can inhibit norepinephrine-induced breast cancer cell migration. We hypothesised that breast cancer patients receiving beta-blockers for hypertension would show reduced metastasis and improved clinical outcome. Three patient subgroups were i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Powe, Desmond G., Voss, Melanie J., Zänker, Kurt S., Habashy, Hany O., Green, Andrew R., Ellis, Ian O., Entschladen, Frank
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2010
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3248123/
https://ncbi.nlm.nih.gov/pubmed/21317458
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados